Sheaff Brock Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.65M Sell
27,067
-2,048
-7% -$119K 0.15% 119
2024
Q4
$1.65M Sell
29,115
-15,431
-35% -$862K 0.14% 123
2024
Q3
$2.3M Buy
44,546
+11,387
+34% +$534K 0.2% 97
2024
Q2
$1.38M Sell
33,159
-795
-2% -$35.6K 0.13% 133
2024
Q1
$1.84M Buy
33,954
+808
+2% +$41.2K 0.12% 124
2023
Q4
$1.7M Sell
33,146
-1,612
-5% -$84.6K 0.13% 117
2023
Q3
$2.02M Sell
34,758
-2,329
-6% -$143K 0.18% 99
2023
Q2
$2.37M Sell
37,087
-2,756
-7% -$185K 0.2% 93
2023
Q1
$2.76M Sell
39,843
-1,307
-3% -$92.2K 0.25% 80
2022
Q4
$2.96M Sell
41,150
-357
-0.9% -$26.9K 0.29% 70
2022
Q3
$2.95M Buy
41,507
+792
+2% +$57.5K 0.32% 70
2022
Q2
$3.13M Sell
40,715
-3,575
-8% -$272K 0.26% 68
2022
Q1
$3.23M Sell
44,290
-12,526
-22% -$841K 0.23% 75
2021
Q4
$3.54M Sell
56,816
-1,192
-2% -$69.9K 0.24% 73
2021
Q3
$3.43M Sell
58,008
-72,417
-56% -$4.77M 0.25% 70
2021
Q2
$8.71M Sell
130,425
-266
-0.2% -$17.3K 0.63% 22
2021
Q1
$8.25M Sell
130,691
-301
-0.2% -$18.7K 0.65% 24
2020
Q4
$8.13M Buy
130,992
+11,591
+10% +$713K 0.68% 21
2020
Q3
$7.2M Sell
119,401
-38,040
-24% -$2.29M 0.66% 20
2020
Q2
$9.26M Sell
157,441
-53
-0% -$3.17K 0.92% 11
2020
Q1
$8.78M Sell
157,494
-15,891
-9% -$971K 1.16% 9
2019
Q4
$11.1M Buy
173,385
+144,781
+506% +$8.29M 1.08% 10
2019
Q3
$1.45M Sell
28,604
-304
-1% -$14.3K 0.16% 96
2019
Q2
$1.31M Sell
28,908
-99,986
-78% -$4.66M 0.14% 104
2019
Q1
$6.15M Buy
128,894
+1,700
+1% +$84.7K 0.75% 29
2018
Q4
$6.61M Sell
127,194
-1,229
-1% -$66K 1.04% 20
2018
Q3
$7.97M Sell
128,423
-1,181
-0.9% -$70.1K 0.75% 20
2018
Q2
$7.17M Sell
129,604
-1,967
-1% -$106K 0.7% 27
2018
Q1
$8.32M Buy
131,571
+2,449
+2% +$158K 0.86% 19
2017
Q4
$7.91M Sell
129,122
-24,730
-16% -$1.55M 1.03% 20
2017
Q3
$9.81M Buy
153,852
+92,715
+152% +$5.41M 1.29% 12
2017
Q2
$3.41M Sell
61,137
-3,862
-6% -$210K 0.45% 53
2017
Q1
$3.54M Buy
64,999
+910
+1% +$49.9K 0.46% 50
2016
Q4
$3.75M Sell
64,089
-5,182
-7% -$283K 0.47% 50
2016
Q3
$3.73M Buy
69,271
+10,901
+19% +$700K 0.5% 47
2016
Q2
$4.29M Sell
58,370
-200
-0.3% -$14.1K 0.54% 45
2016
Q1
$3.74M Sell
58,570
-162
-0.3% -$10.2K 0.46% 45
2015
Q4
$4.04M Buy
+58,732
New +$3.88M 0.46% 47

Other funds holding BMY

Sheaff Brock Investment Advisors's BMY Position: Q1 2025 in Review

Sheaff Brock Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2025, selling an estimated $119K and leaving 27,067 shares worth $1.65M. The position accounts for 0.15% of the portfolio, ranked #119.

Sheaff Brock Investment Advisors first reported a position in BMY in Q4 2015 and has held it in 38 quarters since. The position peaked at $11.1M in Q4 2019. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Sheaff Brock Investment Advisors held 27,067 shares of Bristol-Myers Squibb worth $1.65M as of Q1 2025.
  • Sheaff Brock Investment Advisors sold 2,048 Bristol-Myers Squibb shares in Q1 2025, an estimated $119K.
  • Bristol-Myers Squibb made up 0.15% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #119 holding.
  • Sheaff Brock Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 38 quarters since.
  • Sheaff Brock Investment Advisors's Bristol-Myers Squibb position peaked at $11.1M in Q4 2019.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.